Indraprastha Medical Corporation Ltd

AGM details

• AGM held on 24 September 2026 via Video Conferencing and Other Audio Visual Means.
• Start time 11:30 AM, end time 12:45 PM.
• Notice dated 6 August 2026 referenced for agenda; business transacted as per notice.

Documentation and results

• Voting results and scrutinizer report filed as Annexure I and Annexure II.

AGM Details

• AGM held on 24 September 2026 at 11:30 A.M. via VC/OAVM.
• Chaired by Dr. Prathap C. Reddy.
• Remote e-voting available; e-voting during AGM provided.

Key Resolutions

• Adoption of audited financial statements for year ended 31 March 2026.
• Dividend declaration on equity shares at Rs 4 per share.
• Re-appointment of Prof. Mahesh Verma as director liable to retire by rotation.
• Re-appointment of Dr. Suneeta Reddy as director liable to retire by rotation.
• Ratification of remuneration of Cost Auditor for year ending 31 March 2027.

Voting Results

• Combined voting results to be announced within 48 hours of AGM conclusion.

Dividend

• Dividend proposed at Rs 4 per equity share (40% of face value Rs 10).

Director Changes

• Re-appointment of Prof. Mahesh Verma as director liable to retire by rotation.
• Re-appointment of Dr. Suneeta Reddy as director liable to retire by rotation.

Auditor Appointments

• Cost Auditor remuneration ratification for year ending 31 March 2027.

Indraprastha Medical Corporation Limited trading window closed from Thursday, 1st October, 2026 until 48 hours after the declaration of the unaudited financial results by the Company, for quarter ending 30th September, 2026.

Financial highlights

• Revenue from operations: ₹1,482.51 crore, up 9.3% YoY.
• PAT: ₹183.62 crore, up 14% YoY.
• EPS: ₹20.03 per share (FY25-26).
• Dividend proposed: ₹4 per share; total ₹36.67 crore.
• AGM date 24 Sep 2026; AGM via VC/OAVM.

Operational performance

• Discharges: 63,236; OPD: 607,485; IPD: 5,082.
• Revenue per patient: ₹225,338; Revenue per bed day: ₹69,714.
• Average length of stay: 3.23 days.

Dividends & capital allocation

• Dividend: ₹4 per equity share (40%); tax at source as per law.
• Total dividend proposal ₹36.67 crore; record date 18 Sep 2026.
• Dividend Distribution Policy in place; profits retained as distributable earnings.

Capital structure & liquidity

• No outstanding borrowings as of 31 Mar 2026; credit facilities available but undrawn.
• Credit ratings reaffirmed by ICRA: AA(stable) for term loan/cash credit; A1+ for short-term.
• Healthy current ratio at 2.46x.

Governance & board changes

• Board: 4 Non-Executive Non-Independent, 1 Executive, 8 Independent as of 31 Mar 2026.
• Notable changes: Sudhir Jalan (Ind., joined 6 Aug 2025); Harsh Pati Singhania (Ind., joined 3 Feb 2026).
• Vineeta Rai re-appointed (Ind., 8 Feb 2026); Vinayak Chatterjee ceased (31 Mar 2026).

CSR & ESG highlights

• CSR spend: ₹3.26 crore (₹326 Lacs); 2% of average net profits.
• CSR initiatives span rural development, healthcare, education and research.
• CSRS Committee reconstituted from 1 Apr 2026; chair Prof. Mahesh Verma.

Outlook and risks

• Focus on expanding Centres of Excellence and advanced procedures.
• Leverage Apollo 24|7 and digital platforms to enhance reach.
• Risks include regulatory changes, cost pressures and market competition.

AGM and dividend dates

• AGM 38th to be held on 24 September 2026 via VC/OAVM.
• Cut-off date for voting/attendance fixed at 18 September 2026.
• Record date for dividend for 2025-26 fixed as 18 September 2026.
• Dividend proposed at AGM: Rs 4.00 per share (40% of face value).
• Dividend payable within 30 days from date of declaration.
• Dividend to demat holders based on NSDL/CDSL data as of 18 September 2026.
• Dividend to physical shareholders after valid transmission/transposition requests by 18 September 2026.

Financial results

• Approved unaudited quarterly results for quarter ended 30 June 2026, with Limited Review Report.

AGM

• Scheduled the 38th AGM for 24 September 2026 via video conferencing.

Record date / dividend

• Fixed record date of 18 September 2026 for dividend entitlement and AGM.

Cost auditors appointment

• Re-appointed M/s Devarajan Swaminathan and Co. as Cost Auditors for 2026-27.

Auditor's review

• Review report: no material misstatement found.

Meeting Details

• Meeting on 6 August 2026; time and location not disclosed.

Key Agenda Items

• To consider and approve the unaudited quarterly financial results for quarter ended 30 June 2026.